Article
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2021
Tischkowitz Marc, Balmaña Judith, Foulkes William D, James Paul, Ngeow Joanne, Schmutzler Rita, Voian Nicoleta, Wick Myra J, Stewart Douglas R, Pal Tuya
Abstract excerpt
PURPOSE: PALB2 germline pathogenic variants are associated with increased breast cancer risk and smaller increased risk of pancreatic and likely ovarian cancer. Resources for health-care professionals managing PALB2 heterozygotes are currently limited. METHODS: A workgroup of experts sought to outline management of PALB2 heterozygotes based on current evidence. Peer-reviewed publications from PubMed were...
Topics
- Breast Neoplasms
- Fanconi Anemia Complementation Group N Protein
- Female
- Genetic Predisposition to Disease
- Genetics, Medical
- Genomics
- Germ Cells
- Humans
- Mastectomy
